Skip to content

Clinical trials

Squamous Cell Carcinoma of Head and Neck trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Country / region: Hong Kong Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20121
20131
20141
20171
20181
20191
20201
20211
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Active, not recruiting2
Recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Alentis Therapeutics AG2
Amgen1
Bristol-Myers Squibb1
Gilead Sciences1
MacroGenics1
National Cancer Institute (NCI)1
RAPT Therapeutics, Inc., a member of the GSK plc group of companies1
Sanofi1
The University of Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck13
Carcinoma, Non-Small-Cell Lung5
Head and Neck Neoplasms3
Colorectal Neoplasms2
Esophageal Neoplasms2
Esophageal Squamous Cell Carcinoma2
Nasopharyngeal Carcinoma2
Ovarian Neoplasms2
Triple Negative Breast Neoplasms2
Uterine Cervical Neoplasms2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.